In addition, compared with that in the control group, the expression of NF-κB in the liver of the NAFLD mice increased to a certain extent, and the expression of NF-κB decreased after GLC administration, but the difference was not significant. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.